Mylaxen, preliminary clinical evaluation of a new agent for neuromuscular blockade.
D002317:Cardiovascular Agents; D005449:Fluorenes; D006584:Hexamethonium Compounds; D006801:Humans; D009125:Muscle Relaxants, Central; D019148:Neuromuscular Blockade
D002317:Cardiovascular Agents; D005449:Fluorenes; D006584:Hexamethonium Compounds; D009125:Muscle Relaxants, Central; C005034:hexafluorenium
MUSCLE RELAXANTS